James Kim, M.D., Ph.D.
Department Internal Medicine | Hamon Center for Therapeutic Oncology Research
Graduate Programs Cancer Biology
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.View Clinical Profile
James Kim, M.D., Ph.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Hematology-Oncology. He specializes in lung cancer and other thoracic malignancies.
A native of Seoul, Dr. Kim received his undergraduate degree in chemistry and classical Greek at Amherst College. He earned his medical degree and his doctorate in biophysical chemistry at the University of Rochester, where he also completed his residency in internal medicine. He finished his advanced training with a clinical fellowship in medical oncology at Johns Hopkins School of Medicine and a research postdoctoral fellowship at Stanford University.
Certified by the American Board of Internal Medicine in medical oncology, he joined the UT Southwestern faculty in 2011.
Dr. Kim’s laboratory focuses on fundamental developmental pathways, such as Hedgehog, in the initiation, growth, and metastases of cancers. The laboratory also seeks to understand interactions of these pathways with each other and between tumor epithelia and stroma. His investigations have resulted in 25 publications in peer-reviewed journals.
At UT Southwestern, Dr. Kim instructs both medical and graduate students as a lecturer, dissertation committee member, journal club moderator, and in clinics.
He is a member of the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, and the American Association of Cancer Research.
- Medical School
- University of Rochester School of Medicine and Dentistry (1997)
- Medical School
- University of Rochester School of Medicine and Dentistry (1999)
- University of Rochester/Strong Memorial Hospital (2000), Internal Medicine
- University of Rochester/Strong Memorial Hospital (2002), Internal Medicine
- Johns Hopkins Hospitals & Health System (2006), Medical Oncology
- Other Post Graduate Training
- Stanford University (2010)
- Developmental Pathways
- Hedgehog Signaling Pathway
- Lung Cancer
- Molecularly Targeted Therapy
- Tumor Epithelial-Stromal Interactions
- Posaconazole, a second-generation triazole antifungal drug, inhibits the Hedgehog signaling pathway and progression of basal cell carcinoma.
- Chen B, Trang V, Lee A, Williams NS, Wilson AN, Epstein EH, Tang JY, Kim J Mol. Cancer Ther. 2016 Jan
- Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma.
- Kim DJ, Kim J, Spaunhurst K, Montoya J, Khodosh R, Chandra K, Fu T, Gilliam A, Molgo M, Beachy PA, Tang JY J. Clin. Oncol. 2014 Mar 32 8 745-51
- Simultaneous measurement of smoothened entry into and exit from the primary cilium.
- Kim J, Hsia EY, Kim J, Sever N, Beachy PA, Zheng X PLoS ONE 2014 9 8 e104070
- Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response.
- Myers BR, Sever N, Chong YC, Kim J, Belani JD, Rychnovsky S, Bazan JF, Beachy PA Dev. Cell 2013 Aug 26 4 346-57
- Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.
- Kim J, Aftab BT, Tang JY, Kim D, Lee AH, Rezaee M, Kim J, Chen B, King EM, Borodovsky A, Riggins GJ, Epstein EH, Beachy PA, Rudin CM Cancer Cell 2013 Jan 23 1 23-34
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
- Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA Proc Natl Acad Sci 2011 Mar 15 108 (11) 4453-8
- Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
- Shin K, lee J, Guo N, Kim J, Lim A, Qu L, Mysorekar IU, Beachy PA Nature 2011 Apr 7 472 (7341) 110-4
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- Kim J, Lee JJ, Kim J, Gardner D, Beachy PA Proc Natl Acad Sci 2010 Jul 27 107 (30) 13432-7
- Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth
- Kim J, Tang JY, Gong R, Kim J, Lee JJ, Clemons KV, Chong CR, Chang KS, Fereshteh M, Gardner D, Reya T, Liu JO, Epstein EH, Stevens DA, Beachy PA Cancer Cell 2010 Apr 13 17 (4) 388-99
- Thermodynamics of coaxially stacked helixes with GA and CC mismatches
- Kim J, Walter AE, Turner DH Biochemistry 1996 Oct 29 35 (43) 13753-61
Honors & Awards
- Simmons Cancer Center and American Cancer Society New Investigator Award
- National Lung Cancer Partnership Young Investigator Research Grant
- American Society of Clinical Oncology Young Investigator Award
- International Association for the Study of Lung Cancer (2012)
- American Association for Cancer Research (2003)
- American Society of Clinical Oncology (2002)